Latest Rights Issue News

HITIQ Limited has successfully completed the initial tranche of a $900,000 placement, issuing over 40 million shares with attached options, while director participation awaits shareholder approval.

Alexium International Group Limited has announced a pro rata non-renounceable rights issue to raise approximately AUD 6.77 million, primarily to repay shareholder loans and finance the acquisition of Microtek Laboratories' microencapsulation business.

Jatcorp Limited has announced a fully underwritten pro-rata rights issue to raise approximately $4.2 million, aiming to strengthen working capital and accelerate growth in China and Southeast Asia. Eligible shareholders can subscribe at $0.15 per share with an option for additional shares under a Top-Up Facility.

Koba Resources has completed a $4.35 million placement of 87 million shares at 5 cents each, accompanied by 43.5 million free attaching options exercisable at 8 cents until mid-2028, following shareholder approval.

Pathkey.AI Ltd has announced a pro rata non-renounceable rights issue to raise approximately $920,517, alongside a $2.5 million placement, aiming to fund enhancements to its AI platform and strategic expansion.

Identitii Limited has announced a pro rata non-renounceable rights issue to raise approximately $2.88 million, partially underwritten by Beauvais Capital Pty Ltd. The funds will support the development and commercialisation of its BNDRY platform amid ongoing patent litigation risks.

Identitii Limited launches a $2.9 million rights issue, underwritten up to $2.3 million by its largest shareholder, to accelerate the commercial rollout of its BNDRY platform.

HITIQ Limited has successfully raised $925,000 through an oversubscribed placement, issuing shares at a discount and attaching listed options to support its concussion management technology's commercialisation.

APC Minerals Limited has initiated a fully underwritten pro-rata renounceable entitlement offer to raise approximately $1.38 million at $0.004 per share, aiming to fund its exploration projects and working capital needs.

Clara Resources has successfully placed over 300 million shortfall shares from its recent rights issue, raising nearly $1 million to accelerate development at its Ashford Coking Coal Project and explore new opportunities.

Pathkey.AI has secured A$2.5 million through a placement and launched a nearly A$1 million rights issue to fund expansion of its AI-driven TrialKey platform and pursue strategic acquisitions, alongside key board changes.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.